New drugs for the treatment of tuberculosis : needs, challenges, promise, and prospects for the future /Lienhardt, Christian Raviglione, M. Spigelman, M. Hafner, R. Jaramillo, E. Hoelscher, M. Zumla, A. Gheuens, J. INFECTION TRAITEMENT MEDICAL MEDICAMENT SENSIBILITE RESISTANCE SIDA ENFANT TOLERANCE EFFICACITE REGLEMENTATION TUBERCULOSE COMBINAISON MEDICAMENTEUSE COINFECTION INTERACTION MEDICAMENTEUSE SECURITE SANITAIRE RECOMMANDATION ANTIRETROVIRAUX ACCES AUX SOINS FLUOROQUINOLONE GATIFLOXACINE MOXIFLOXACINE RIFAPENTINE ISONIAZIDE BEDAQUILINE DELAMANIDE NITROIMIDAZOLE PYRAZINAMIDE 2012 text https://www.documentation.ird.fr/hor/fdi:010059621 fdi:010059621 Lienhardt Christian, Raviglione M., Spigelman M., Hafner R., Jaramillo E., Hoelscher M., Zumla A., Gheuens J.. New drugs for the treatment of tuberculosis : needs, challenges, promise, and prospects for the future. 2012, 205 (suppl. 2), S241-S249 EN